Paxlovid Boceprevir Intermediate CAS 565456-77-1 Su'ega ≥99.0%
Fa'atauga Fa'atauga PF-07321332 Paxlovid Feso'ota'i Tulaga Fa'atasi ma le Tulaga Maualuga
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9
Igoa Vailaau | (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride |
Synonyms | Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate Hydrochloride |
Numera CAS | 565456-77-1 |
CAT Numera | RF-PI318 |
Tulaga Fa'asoa | I Fa'atauga, Oloa Fua e O'o i Tone |
Fuafua mole | C9H15NO2.ClH |
Molecular Weight | 205.683 |
Fa'ailoga | Ruifu Chemical |
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'epa'e i le Pa'epa'e Pa'epa'e |
Faailoaina A | IR: E tutusa ma Reference Substance |
Faailoaga B | Taimi Taofi: Tutusa ma Mea Fa'asino |
Enantiomer | ≤0.15% |
Fa'aleaga Fa'atatau (e le HPLC) | |
Le iloa le mama | ≤0.20% |
Aofa'i Fa'aleaga | ≤1.0% |
Vai | ≤0.50% |
Toega i luga o le mumu | ≤0.10% |
Metala mamafa | ≤20ppm |
Su'ega | ≥99.0% |
Tulaga Su'ega | Pisinisi Tulaga |
Fa'aoga | Intermediate of PF-07321332 Paxlovid (CAS 2628280-40-8) ma Boceprevir (CAS 394730-60-0) |
afifi: Fagu, taga pepa alumini, pusa pepa, 25kg / Paʻu, poʻo le tusa ai ma manaʻoga o tagata faʻatau.
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama, susu ma le afaina o meaola faalafua.
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride (CAS 565456-77-1) o se azabicyclohexane fa'aaogaina i le sauniuniga o le hepatitis C. siama (HCV) NS3 serine protease inhibitor.O le ogatotonu ole PF-07321332 Paxlovid (CAS 2628280-40-8) ma Boceprevir (CAS 394730-60-0).O le PF-07321332 o se fa'ama'i malosi ma fa'afofoga fa'afofoga SARS-CoV 3C-pei o le protease (3CLPRO).O le PF-07321332 o loʻo faʻatatau i le SARS-CoV-2 virus ma e mafai ona faʻaoga mo le COVID-19 suʻesuʻega.Boceprevir (INN, igoa tau fefaʻatauaʻiga Victrelis) o se inhibitor protease faʻaaogaina e fai ma togafitiga mo le hepatitis C genotype 1. E fusifusia i le HCV nonstructural 3 NS3 (HCV) nofoaga galue.O lo'o atia'e e Schering-Plough, ae o lea ua atia'e e Merck talu ona maua le Schering i le 2009. Na fa'amaonia e le FDA ia Me 13, 2011.